• Mashup Score: 1

    While predictive biomarkers are not routinely used in sarcoma clinical practice currently, emerging biomarkers are being developed alongside clinical advancements. Novel therapies and predictive biomarkers will be essential for individualizing future approaches to sarcoma management and improving pa …

    Tweet Tweets with this article
    • https://t.co/AUDwrArbGg Happy to highlight this excellent review article by my colleague @candace_haddox in collaboration with @richardriedelmd . Some of these biomarkers will make their way into clinical practice, I am sure.